File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Magnetic resonance cholangiogram patterns and clinical profiles of ketamine-related cholangiopathy in drug users

TitleMagnetic resonance cholangiogram patterns and clinical profiles of ketamine-related cholangiopathy in drug users
Authors
KeywordsAlkaline phosphatase
Biliary
Cholangiogram
Ketamine
Magnetic resonance cholangiography
Substance abuse
Issue Date2018
PublisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep
Citation
Journal of Hepatology, 2018, v. 69 n. 1, p. 121-128 How to Cite?
AbstractBackground & Aims: Recreational ketamine use has emerged as an important health and social issue worldwide. Although ketamine is associated with biliary tract damage, the clinical and radiological profiles of ketamine-related cholangiopathy have not been well described. Methods: Chinese individuals who had used ketamine recreationally at least twice per month for six months in the previous two years via a territory-wide community network of charitable organizations tackling substance abuse were recruited. Magnetic resonance cholangiography (MRC) was performed, and the findings were interpreted independently by two radiologists, with the findings analysed in association with clinical characteristics. Results: Among the 343 ketamine users referred, 257 (74.9%) were recruited. The mean age and ketamine exposure duration were 28.7 (±5.8) and 10.5 (±3.7) years, respectively. A total of 159 (61.9%) had biliary tract anomalies on MRC, categorized as diffuse extrahepatic dilatation (n = 73), fusiform extrahepatic dilatation (n = 64), and intrahepatic ductal changes (n = 22) with no extrahepatic involvement. Serum alkaline phosphatase (ALP) level (odds ratio [OR] 1.007; 95% CI 1.002–1.102), lack of concomitant recreational drug use (OR 1.99; 95% CI 1.11–3.58), and prior emergency attendance for urinary symptoms (OR 1.95; 95% CI 1.03–3.70) had high predictive values for biliary anomalies on MRC. Among sole ketamine users, ALP level had an AUC of 0.800 in predicting biliary anomalies, with an optimal level of ≥113 U/L having a positive predictive value of 85.4%. Cholangiographic anomalies were reversible after ketamine abstinence, whereas decompensated cirrhosis and death were possible after prolonged exposure. Conclusions: We have identified distinctive MRC patterns in a large cohort of ketamine users. ALP level and lack of concomitant drug use predicted biliary anomalies, which were reversible after abstinence. The study findings may aid public health efforts in combating the growing epidemic of ketamine abuse. Lay summary: Recreational inhalation of ketamine is currently an important substance abuse issue worldwide, and can result in anomalies of the biliary system as demonstrated by magnetic resonance imaging. Although prolonged exposure may lead to further clinical deterioration, such biliary system anomalies might be reversible after ketamine abstinence. Clinical trial number: NCT02165488.
Persistent Identifierhttp://hdl.handle.net/10722/252126
ISSN
2017 Impact Factor: 15.04
2015 SCImago Journal Rankings: 4.570
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorSeto, WKW-
dc.contributor.authorMak, SK-
dc.contributor.authorChiu, WHK-
dc.contributor.authorVardhanabhuti, V-
dc.contributor.authorWong, HF-
dc.contributor.authorLeong, HT-
dc.contributor.authorLee, P-
dc.contributor.authorHo, YC-
dc.contributor.authorLee, CK-
dc.contributor.authorCheung, KSM-
dc.contributor.authorYuen, RMF-
dc.contributor.authorLeung, WK-
dc.date.accessioned2018-04-11T02:06:14Z-
dc.date.available2018-04-11T02:06:14Z-
dc.date.issued2018-
dc.identifier.citationJournal of Hepatology, 2018, v. 69 n. 1, p. 121-128-
dc.identifier.issn0168-8278-
dc.identifier.urihttp://hdl.handle.net/10722/252126-
dc.description.abstractBackground & Aims: Recreational ketamine use has emerged as an important health and social issue worldwide. Although ketamine is associated with biliary tract damage, the clinical and radiological profiles of ketamine-related cholangiopathy have not been well described. Methods: Chinese individuals who had used ketamine recreationally at least twice per month for six months in the previous two years via a territory-wide community network of charitable organizations tackling substance abuse were recruited. Magnetic resonance cholangiography (MRC) was performed, and the findings were interpreted independently by two radiologists, with the findings analysed in association with clinical characteristics. Results: Among the 343 ketamine users referred, 257 (74.9%) were recruited. The mean age and ketamine exposure duration were 28.7 (±5.8) and 10.5 (±3.7) years, respectively. A total of 159 (61.9%) had biliary tract anomalies on MRC, categorized as diffuse extrahepatic dilatation (n = 73), fusiform extrahepatic dilatation (n = 64), and intrahepatic ductal changes (n = 22) with no extrahepatic involvement. Serum alkaline phosphatase (ALP) level (odds ratio [OR] 1.007; 95% CI 1.002–1.102), lack of concomitant recreational drug use (OR 1.99; 95% CI 1.11–3.58), and prior emergency attendance for urinary symptoms (OR 1.95; 95% CI 1.03–3.70) had high predictive values for biliary anomalies on MRC. Among sole ketamine users, ALP level had an AUC of 0.800 in predicting biliary anomalies, with an optimal level of ≥113 U/L having a positive predictive value of 85.4%. Cholangiographic anomalies were reversible after ketamine abstinence, whereas decompensated cirrhosis and death were possible after prolonged exposure. Conclusions: We have identified distinctive MRC patterns in a large cohort of ketamine users. ALP level and lack of concomitant drug use predicted biliary anomalies, which were reversible after abstinence. The study findings may aid public health efforts in combating the growing epidemic of ketamine abuse. Lay summary: Recreational inhalation of ketamine is currently an important substance abuse issue worldwide, and can result in anomalies of the biliary system as demonstrated by magnetic resonance imaging. Although prolonged exposure may lead to further clinical deterioration, such biliary system anomalies might be reversible after ketamine abstinence. Clinical trial number: NCT02165488.-
dc.languageeng-
dc.publisherElsevier BV. The Journal's web site is located at http://www.elsevier.com/locate/jhep-
dc.relation.ispartofJournal of Hepatology-
dc.subjectAlkaline phosphatase-
dc.subjectBiliary-
dc.subjectCholangiogram-
dc.subjectKetamine-
dc.subjectMagnetic resonance cholangiography-
dc.subjectSubstance abuse-
dc.titleMagnetic resonance cholangiogram patterns and clinical profiles of ketamine-related cholangiopathy in drug users-
dc.typeArticle-
dc.identifier.emailSeto, WKW: wkseto@hku.hk-
dc.identifier.emailChiu, WHK: kwhchiu@hku.hk-
dc.identifier.emailVardhanabhuti, V: varv@hku.hk-
dc.identifier.emailCheung, KSM: cks634@hku.hk-
dc.identifier.emailYuen, RMF: mfyuen@hku.hk-
dc.identifier.emailLeung, WK: waikleung@hku.hk-
dc.identifier.authoritySeto, WKW=rp01659-
dc.identifier.authorityChiu, WHK=rp02074-
dc.identifier.authorityVardhanabhuti, V=rp01900-
dc.identifier.authorityCheung, KSM=rp02532-
dc.identifier.authorityYuen, RMF=rp00479-
dc.identifier.authorityLeung, WK=rp01479-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1016/j.jhep.2018.03.006-
dc.identifier.pmid29551711-
dc.identifier.scopuseid_2-s2.0-85044970150-
dc.identifier.hkuros284788-
dc.identifier.volume69-
dc.identifier.issue1-
dc.identifier.spage121-
dc.identifier.epage128-
dc.identifier.isiWOS:000436584100016-
dc.publisher.placeNetherlands-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats